ACRV
Acrivon Therapeutics, Inc.
2.10$
-4.2%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.00 | 0.06 | 0.05 | 0.02 | 0.03 | 0.04 | |
| 0.00 | -0.06 | -0.05 | -0.02 | -0.03 | -0.04 | |
| 0.14 | 1.06 | 1.09 | 2.06 | 1.67 | 1.56 | |
| 0.10 | 0.19 | 0.40 | 0.95 | 0.66 | 0.63 | |
| 0.25 | 1.25 | 1.49 | 3.02 | 2.30 | 2.15 | |
| -0.25 | -1.25 | -1.49 | -3.05 | -2.33 | -2.18 | |
| – | 0.00 | 0.07 | – | – | – | |
| -0.41 | -1.26 | -1.42 | -2.74 | -2.10 | -2.02 | |
| -0.01 | -0.02 | -0.07 | 0.00 | – | – | |
| -0.41 | -1.26 | -1.35 | -2.74 | -2.10 | -2.02 | |
| -0.41 | -1.26 | -1.47 | -2.71 | -2.08 | -1.99 |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.